KIMS Q3 Results Review - Strong Operating Cash Flows, ROCE: Axis Securities
Krishna Institute of Medical Sciences consolidated profit after tax stood at Rs 77 crore, down 6.7%% YoY, which was led by low operating profitability during the quarter.
Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
The Management of the Company will be attending the IIFL''s 15th Enterprising India Global Investors'' Conference in Mumbai on February 14, 2024. Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Management is attending the Investor conference in Mumbai organised by Axis Capital India. Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of Earnings conference call with Analyst/Investor KIMS Q3 Results Review - Weak Quarter; Negative Operating Leverage: Prabhudas Lilladher
Cyclone in AP, state elections in Telangana and shifting of Sunshine unit impacted profitability. Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio Recording of conference call with Investors / Analyst for Q3 FY24. Q3FY24 Quarterly Result Announced for Krishna Institute of Medical Sciences Ltd.
Healthcare Facilities company Krishna Institute of Medical Sciences announced Q3FY24 results: Gross revenue at Rs 609 crore for the Q3FY24, an increase of 7.1% on a YoY and a decrease of 7.1% on a QoQ basis. Reported operating EBITDA of Rs 150 crore for the Q3FY24, a decrease of 4.6% YoY and 16.5% QoQ basis. Reported EBITDA margin at 24.7% vs. 27.7% in Q3FY23 and 27.5% in Q2FY24. PAT at Rs 77 crore in Q3FY24 against Rs 82 crore and Rs 101 crore in Q3FY23 and Q2FY24 respectively. Conducted 3.92 lakh OPD consults in Q3FY24, up by 2.7% on YoY and decreased by 7.3% on QoQ basis. Bed occupancy in Q3FY24 at 72.2%, up by 3.9% on YoY and down by 4.2% QoQ basis. ARPOB decreased marginally to Rs 30,741 in Q3FY24, a 3.1% increase YoY and 1.3% decrease on QoQ basis. Cash and Cash Equivalents at Rs 105 crore in Q3FY24.Net Debt to Equity ratio at 0.33 Announcing Q3 results, Dr. B Bhaskar Rao, CMD, KIMS Hospitals, said: “ We have seen a dip in patient footfalls this quarter. Traditionally, this happens to be slack season on account of festivals. Besides, the cyclone in Andhra Pradesh and assembly elections in Telangana have shown some impact. But I am particularly pleased to see that all our units have continued to produce excellent clinical outcomes. We should be opening our Nashik unit in Q1FY25. I am optimistic that we are on track to achieve our targets for FY24.” Result PDF Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed a copy of the newspaper publication of the unaudited financial results for the 3rd quarter and nine months ended 31st December 2023 published on 04th February 2024 in the Financial Express (English) and Navatelangana (Telugu).
KIMS Hospital Q3 net profit down 6.4% to Rs 76.5 crore
Bed occupancy in the quarter was at 72.2 percent, up by 3.9 percent compared with the same period a year ago. Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation